NYSE$ENOV
Enovis Corp · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
Reported strong sales growth and margin expansion.
Enovis reported a strong second quarter with a 23% increase in sales and adjusted margin expansion. The company reported a net loss of $0.34 per share, but adjusted net income per diluted share was $0.62. Enovis is on track to accelerate growth and profitability into 2025.
- Second-quarter sales grew by 23% on a reported basis and 5% on a comparable sales basis.
- Net loss from continuing operations was $0.34 per share, while adjusted earnings per diluted share was $0.62.
- FDA 510k clearance received for Arvis 2.0 Shoulder and Altivate Reverse Glenoid system, with launches expected in Q3 2024.
- Adjusted EBITDA margin improved 190 basis points year over year, driven by the addition of Lima, product and geographic mix, new product introductions, and execution on key EGX initiatives
Headline financials
Revenue & EPS history
Enovis · Revenue · Quarterly
$525M
Revenue by segment
Enovis · $131M total across 1 segment · Q2 2022
- Reconstructive$131M—100.0%
Forward guidance
Enovis narrowed its revenue range and reaffirmed adjusted EBITDA expectations for 2024. Full-year revenue is estimated at $2.08-$2.13 billion, and adjusted EBITDA is forecasted to be $368-$383 million. The Company also raised its full-year adjusted earnings per diluted share guidance from $2.52-$2.67 to $2.62-$2.77.
Tailwinds
- Full-year revenue is estimated at $2.08-$2.13 billion.
- Adjusted EBITDA is forecasted to be $368-$383 million.
- Adjusted earnings per diluted share guidance raised from $2.52-$2.67 to $2.62-$2.77.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2024
+1.6%
Avg return
Earnings day
+1.3%
Avg return
5 days after
+0.1%
Avg return
30 days after
52%
33 / 64 earnings
Positive
+21.3%
Q3 2011
Best reaction
-18.7%
Q1 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +9.7% | +4.0% | -4.5% | |
| Q4 2025 | +13.8% | +13.3% | -2.2% | |
| Q3 2025 | -9.7% | +0.1% | -14.2% | |
| Q1 2025 | -2.9% | +9.1% | -7.2% | |
| Q4 2024 | -4.9% | -10.1% | -10.3% | |
| Q3 2024 | +10.6% | +9.3% | +10.0% | |
| Q2 2024 | +4.0% | +1.0% | +3.5% | |
| Q1 2024 | -7.5% | -5.7% | -9.3% | |
| Q4 2023 | +4.3% | +2.0% | -0.1% | |
| Q3 2023 | +4.0% | +3.2% | +8.8% | |
| Q2 2023 | -5.6% | -8.1% | -10.0% | |
| Q1 2023 | -1.8% | -3.7% | -3.9% | |
| Q4 2022 | -9.6% | -6.4% | -18.9% | |
| Q3 2022 | -3.4% | +7.4% | +15.9% | |
| Q2 2022 | -3.7% | -4.4% | -17.5% | |
| Q1 2022 | +5.7% | +5.9% | +7.4% | |
| Q4 2021 | +0.9% | +2.8% | -3.7% | |
| Q3 2021 | +0.4% | -1.4% | -14.9% | |
| Q2 2021 | +3.6% | +2.1% | +8.5% | |
| Q1 2021 | -1.1% | -5.9% | -3.2% | |
| Q4 2020 | +13.7% | +17.2% | +16.8% | |
| Q3 2020 | -4.1% | +3.0% | +30.8% | |
| Q2 2020 | +6.8% | +13.0% | +8.1% | |
| Q1 2020 | +14.6% | +6.6% | +33.4% | |
| Q4 2019 | +2.8% | -5.1% | -55.3% | |
| Q3 2019 | +9.6% | +11.5% | +6.0% | |
| Q2 2019 | +7.9% | +5.3% | +15.1% | |
| Q1 2019 | -5.5% | -6.5% | -4.7% | |
| Q4 2018 | +5.3% | +6.8% | +15.0% | |
| Q3 2018 | -0.3% | +0.8% | -12.5% | |
| Q2 2018 | +5.5% | +0.8% | +12.9% | |
| Q1 2018 | +2.2% | +5.3% | +1.1% | |
| Q4 2017 | -8.5% | -14.2% | -11.2% | |
| Q3 2017 | -12.7% | -13.7% | -14.0% | |
| Q2 2017 | +1.1% | +0.9% | -4.3% | |
| Q1 2017 | +1.9% | +2.4% | +7.4% | |
| Q4 2016 | +2.2% | -0.5% | -5.0% | |
| Q3 2016 | +7.8% | +5.4% | +26.9% | |
| Q2 2016 | +0.0% | -3.2% | +3.4% | |
| Q1 2016 | -18.7% | — | — | |
| Q4 2015 | +18.9% | — | — | |
| Q3 2015 | -6.5% | — | — | |
| Q2 2015 | -5.1% | — | — | |
| Q1 2015 | -0.8% | — | — | |
| Q4 2014 | -0.9% | — | — | |
| Q3 2014 | -5.1% | — | — | |
| Q2 2014 | -6.9% | — | — | |
| Q1 2014 | -3.4% | — | — | |
| Q4 2013 | +7.0% | — | — | |
| Q3 2013 | +0.0% | — | — | |
| Q2 2013 | -0.1% | — | — | |
| Q1 2013 | +4.5% | — | — | |
| Q4 2012 | -5.8% | — | — | |
| Q3 2012 | -2.7% | — | — | |
| Q2 2012 | +5.2% | — | — | |
| Q1 2011 | -5.7% | — | — | |
| Q1 2012 | +1.3% | — | — | |
| Q4 2011 | -1.9% | — | — | |
| Q3 2011 | +21.3% | — | — | |
| Q2 2011 | +16.2% | — | — | |
| Q4 2010 | +16.2% | — | — | |
| Q2 2010 | +16.2% | — | — | |
| Q3 2010 | +1.0% | — | — | |
| Q1 2010 | +0.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro